A modified whole blood partial thromboplastin test for the assessment of heparinization.
Current methods of assessment of heparinization are either inconvenient as bedside procedures or lack correlation with the Lee-White whole blood clotting time over the therapeutic range. A new thromboplastin time (CAT time) has been developed to overcome these disadvantages by offering uniform contact activation. The test makes use of a partial thromboplastin activated by celite-adsorbed "contact factor", thus eliminating the activation phase of the activated partial thromboplastin time. Preliminary experiments suggest that this modification will be helpful in the study of "contact factor" deficiencies.
D001780:Blood Coagulation Tests; D004355:Drug Stability; D005069:Evaluation Studies as Topic; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D008722:Methods; D013696:Temperature; D013923:Thromboembolism / Q000188:drug therapy; D013925:Thromboplastin; D013997:Time Factors
D006493:Heparin; D013925:Thromboplastin